Novo says Ozempic to be eligible for US price negotiations in less …
WEB4 hours ago · Novo Nordisk's blockbuster diabetes drug Ozempic will be eligible for U.S. government's price negotiations in less than a year based on current criteria, the Danish drugmaker's CEO Lars Fruergaard ...
Wegovy-maker Novo Nordisk buys land in Denmark for potential …
WEBCOPENHAGEN, July 23 (Reuters) - Novo Nordisk (NOVOb.CO), the maker of weight-loss drug Wegovy, earlier this month bought a 200-acre site in Denmark's third largest city Odense and will begin...
Novo Nordisk's market value of $570 billion is now bigger
WEBMay 1, 2024 · Novo’s market capitalization of more than $570 billion is bigger than the Danish economy. Its philanthropic foundation is now the world’s largest, with assets twice those of the Gates...
Novo Nordisk Growth Isn’t Big Risk to Denmark’s Economy, PM …
WEB21 hours ago · Danish Prime Minister Mette Frederiksen said she’s “extremely proud” of the country’s corporate champions, and rejected concerns that any downturn at pharma giant Novo Nordisk A/S would ...
News Details - novonordisk.com
WEB4 days ago · About Novo Nordisk. Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases, built upon our heritage in diabetes. We do so by pioneering scientific breakthroughs, expanding access to our …
How Ozempic Is Transforming a Small Danish Town
WEBApr 20, 2024 · In Kalundborg, population under 17,000, Novo Nordisk is making huge investments to increase production of its popular diabetes and weight-loss drugs, Ozempic and Wegovy.
Ozempic and Wegovy, Novo Nordisk’s Weight Loss Drugs, Reshape Denmark…
WEBAug 28, 2023 · Novo Nordisk, the Danish company behind two popular obesity medications, is reaping huge profits and is now responsible for most of the country’s economic growth.
Latest news - Novo Nordisk
WEBAug 6, 2024 · Novo Nordisk's sales increased by 24% in Danish kroner and by 25% at constant exchange rates to DKK 133.4 billion in the first six months of 2024. Read more. News archive. Featured stories. PRODUCTION. Expanding our fill-finish capacity.
News Details - Novo Nordisk
WEBNov 9, 2023 · In 2021-22, Novo Nordisk announced investments of an additional 18 billion Danish kroner, building four new production facilities and rebuilding three existing facilities. Novo Nordisk is a leading global healthcare company, …
Novo takes aim at obesity drug shortages with $6B manufacturing …
WEBNov 10, 2023 · Novo Nordisk plans to invest $6 billion to expand its drug manufacturing capacity as it tries to meet skyrocketing demand for its popular obesity and diabetes medicines Wegovy and Ozempic. The investment, announced by the Danish drugmaker Friday, will be spread over the next six years and builds on the company’s existing capital spending plans.
Skip to content